[Corrigendum] Carvacrol may alleviate vascular inflammation in diabetic db/db mice.
carvacrol
endothelial dysfunction
toll‑like receptor 4/nuclear factor‑κB signaling pathway
type 2 diabetes mellitus
vascular inflammation
Journal
International journal of molecular medicine
ISSN: 1791-244X
Titre abrégé: Int J Mol Med
Pays: Greece
ID NLM: 9810955
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
01
09
2019
accepted:
25
02
2020
medline:
18
8
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
ppublish
Résumé
Following the publication of the above article, the authors contacted the Editorial Office to explain that they made a couple of inadvertent errors in the assembly of the data panels showing the results of immunohistochemical experiments in Fig. 5K on p. 983 (the 'TLR4' experiments); essentially, the data panels selected for the '10 mg/mg Carvacrol' and '5 mg/kg Carvacrol' experiments were copied across from those shown for the 'NF‑κB' experiments in the row above (Fig. 5I). The revised version of Fig. 5, showing the correct data for the'10 mg/mg Carvacrol' and '5 mg/kg Carvacrol' experiments in Fig. 5K, is shown on the next page. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of
Identifiants
pubmed: 37594124
doi: 10.3892/ijmm.2023.5293
pii: 90
pmc: PMC10500219
doi:
pii:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : ErratumFor